MA37957A1 - Methods of treating alzheimer's disease and associated pharmaceutical compositions - Google Patents

Methods of treating alzheimer's disease and associated pharmaceutical compositions

Info

Publication number
MA37957A1
MA37957A1 MA37957A MA37957A MA37957A1 MA 37957 A1 MA37957 A1 MA 37957A1 MA 37957 A MA37957 A MA 37957A MA 37957 A MA37957 A MA 37957A MA 37957 A1 MA37957 A1 MA 37957A1
Authority
MA
Morocco
Prior art keywords
methods
disease
pharmaceutical compositions
treating alzheimer
associated pharmaceutical
Prior art date
Application number
MA37957A
Other languages
French (fr)
Inventor
Ellen Schmidt
Johan Areberg
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2013/068516 external-priority patent/WO2014037532A1/en
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of MA37957A1 publication Critical patent/MA37957A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne des procédés de traitement de la démence comprenant l'administration d'une dose quotidienne efficace de n-(2-(6-fluoro-1h-indol-3-yl)éthyl-(2,2,3,3-tétrafluoropropoxy)benzylamine pour améliorer ou augmenter l'effet d'un inhibiteur de l'acétylcholinestérase.The present invention relates to methods of treating dementia comprising administering an effective daily dose of n- (2- (6-fluoro-1H-indol-3-yl) ethyl- (2,2,3,3 tetrafluoropropoxy) benzylamine to enhance or enhance the effect of an acetylcholinesterase inhibitor.

MA37957A 2012-09-09 2015-03-30 Methods of treating alzheimer's disease and associated pharmaceutical compositions MA37957A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261698664P 2012-09-09 2012-09-09
PCT/EP2013/068516 WO2014037532A1 (en) 2012-09-09 2013-09-06 Methods of treating alzheimer's disease and pharmaceutical compositions thereof

Publications (1)

Publication Number Publication Date
MA37957A1 true MA37957A1 (en) 2017-01-31

Family

ID=58504087

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37957A MA37957A1 (en) 2012-09-09 2015-03-30 Methods of treating alzheimer's disease and associated pharmaceutical compositions

Country Status (2)

Country Link
MA (1) MA37957A1 (en)
UA (1) UA113770C2 (en)

Also Published As

Publication number Publication date
UA113770C2 (en) 2017-03-10

Similar Documents

Publication Publication Date Title
EA201590353A1 (en) METHODS OF TREATMENT OF ALZHEIMER'S DISEASE AND PHARMACEUTICAL COMPOSITIONS
PH12020500265A1 (en) Indole carboxamides compounds useful as kinase inhibitors
MA33467B1 (en) Primary drugs include insulin-linking facilities
MA33295B1 (en) NEW FORMULATION OF DICLOFENAC
PH12017500444A1 (en) Pharmaceutical compositions comprising a dextromethorphan compound and quinidine for the treatment of agitation in dementia
EA201300471A1 (en) SUBSTITUTED 6-AMINONICOTINAMIDES AS KCNQ2 / 3 MODULATORS
MA40768B1 (en) Mono or di-substituted indole derivatives as dengue virus replication inhibitors
MA40769A (en) INDOLES MONO OR DI-SUBSTITUTES USED AS DENGUE VIRUS REPLICATION INHIBITORS
UA113538C2 (en) FLUOROMETHYL-5,6-DIHYDRO-4H- $ 1,3] OXAZINES
MA38810A1 (en) Inhibitors of rorc2 related methods of use
MX2015001917A (en) Pharmaceutical compositions of memantine.
PH12014502623B1 (en) Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-benzooxazinyls as bace1 inhibitors
EA201492097A1 (en) 5-AMINO [1,4] TIAZINS AS BETA SECRETASE INHIBITORS 1
MA39447A1 (en) (s) -pirlindole or its pharmaceutically acceptable salts for use in medicine
EA201790315A1 (en) Modulators of Liver X-Receptors
MA39448B1 (en) (r) -pirlindole and its pharmaceutically acceptable salts for medical use
MA37957A1 (en) Methods of treating alzheimer's disease and associated pharmaceutical compositions
MA39533A1 (en) Compounds, pharmaceutical composition and their use in the treatment of neurodegenerative diseases
NZ727251A (en) Novel polymorphic form of n-[2-(6-fluoro-1h-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluoropropoxy)benzylamine hydrochloride for the treatment of alzheimer’s
EA201401142A1 (en) SUBSTITUTED 6-AMINONICOTINAMIDES, BEARING IT-CONTAINING GROUP, AS KCNQ2 / 3 MODULATORS
MA39446A1 (en) Pharmaceutical compositions for treating infectious diseases
FR3042191B1 (en) 1,4,8-TRIAZAPHENANTHRENE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES